EXHIBIT 11.1
SONUS PHARMACEUTICALS, INC.
COMPUTATION OF NET INCOME (LOSS) PER SHARE
Three Months Ended Nine Months Ended
September 30, September 30,
----------------------------- -------------------------------
1996 1995 1996 1995
---------- ----------- ----------- -----------
Net income (loss) .............................. $2,801,745 $(1,947,175) $ (925,037) $(2,838,157)
========== =========== =========== ===========
Weighted average shares outstanding ............ 8,490,201 1,952,864 8,467,100 1,963,843
Net effect of stock option exercised and stock
options and warrants granted during the 12
months prior to the Company's filing of its
initial public offering, calculated using the
treasury stock method at the offering price
of $7 per share, and treated as outstanding
for all periods prior to the closing of the
initial public offering ...................... -- 97,196 -- 97,730
Net effect of common stock equivalents
calculated using the treasury stock method ... 640,790 -- -- --
---------- ----------- ----------- -----------
Shares used in computation of net income
(loss) per share ............................. 9,130,992 2,050,060 8,467,100 2,061,573
========== =========== =========== ===========
Net income (loss) per share .................... $ 0.31 $ (0.95) $ (0.11) $ (1.38)
========== =========== =========== ===========
12